TET1 and breast carcinoma: The noted repression of TET1 expression in breast cancer correlates with NF-κB signaling and infiltration of immune cells in breast cancer; in addition to the recruitment of p65/RelA onto its consensus elements within the TET1 promoter in breast cancer cells (Figure 5c).